Immunological, Cognitive, and Psychiatric Outcomes After Initiating Efavirenz- and Dolutegravir-based Antiretroviral Therapy During Acute Human Immunodeficiency Virus Infection
暂无分享，去创建一个
J. Ananworanich | V. Valcour | S. Vasan | S Spudich | N. Phanuphak | S. Pinyakorn | E. Kroon | D. Hsu | C. Sacdalan | P. Chan | S. Sriplienchan | Bohyung Yoon | D. Colby | R. Paul